Stepping up the Fight: Industry Collaboration to End HIV, Tuberculosis and Malaria
In this report, we have brought together highlights on how we are advancing our work in HIV, TB and malaria, with 14 exemplary case studies that illustrate some of our contributions to support the elimination of these diseases.
We have the opportunity to achieve the SDGs over the next 11 years, requiring increased collaborations across sectors — we invite all actors to explore our work and engage with us as we deepen the quality and impact of our programs
Related news and resources
IFPMA-INTERFARMA-FIFARMA statement on the Rio de Janeiro Declaration of the G20 Health Ministers
The innovative pharmaceutical industry, represented by IFPMA, INTERFARMA and FIFARMA reiterates its commitment to the G20 health priorities, reaffirmed in the Rio de Janeiro Declaration.
Read moreWHO EMRO RC71: Regional flagship initiative 1: Expanding equitable access to medical products
On 14 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on the Regional flagship initiative 1: Expanding equitable access to medical products.
Read moreThe Value of Reference Agency Assessment Reports in Enabling Regulatory Reliance
Access to information, including the assessment documents of reference national regulatory agencies (NRA), is a key enabler of regulatory risk-based decision making. It promotes an understanding of what was reviewed by the reference NRA, provides a rationale for decision making and promotes confidence and trust. The Centre for Innovation in Regulatory Science (CIRS) has published...
Read more